Results 101 to 110 of about 45,130 (266)

Investigation into the Pancreatic Pathogenesis of SFTSV across Multiple Levels

open access: yesAdvanced Science, Volume 13, Issue 1, 5 January 2026.
A retrospective analysis revealed that 17.6% of severe fever with thrombocytopenia syndrome (SFTS) patients met the diagnostic criteria for clinically confirmed pancreatitis. Using human pancreatic organoids and murine models demonstrated that SFTSV exhibits a specific pancreatic tropism, leading to cell death and initiating a strong inflammatory ...
Xiaohan Liu   +10 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Analogues and the Risk of Recurrent Pancreatitis in Diabetic Patients With History of Pancreatitis or Elevated Lipase: Retrospective Cohort Analysis

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.
ABSTRACT Aims The use of glucagon‐like peptide‐1 (GLP1) analogues has increased due to benefits in glycaemic control, weight loss, and cardiorenal protection. However, concerns persist regarding their potential link to pancreatitis. We assessed this link in high‐risk patients with a history of pancreatitis or elevated lipase enzyme.
Bronya Calvarysky   +6 more
wiley   +1 more source

Causal effects from nonalcoholic fatty liver disease on cholelithiasis: A mendelian randomization study

open access: yesHealth Science Reports
Background and Aims Both nonalcoholic fatty liver disease (NAFLD) and cholelithiasis are highly prevalent hepatobiliary diseases with risk of progression into severe outcomes.
Yin‐Shi Su   +2 more
doaj   +1 more source

Cholelithiasis ascomorbidity polycystic ovary syndrome disease [PDF]

open access: yesГинекология, 2015
Polycystic ovary syndrome (PCOS) is a complex interdisciplinary problem in connection with the involvement in the pathogenesis not only of reproductive system, but also multifaceted metabolic disorders, many of which are pathognomonic for cholelithiasis.
Yu B Uspenskaya, I V Kuznetsova
doaj  

Gallstone disease as a clinical marker of metabolic syndrome

open access: yesОжирение и метаболизм, 2018
The prevalence of cholelithiasis, its close pathogenetic connection with metabolic syndrome, high frequency of surgical intervention, significant economic losses put forward this comorbid pathology in a number of leading problems of modern clinical ...
Andrey A. Svistunov   +3 more
doaj   +1 more source

Intrahepatic cholestasis of pregnancy : genetic background, epidemiology and hepatobiliary consequences [PDF]

open access: yes, 2006
Intrahepatic cholestasis of pregnancy (ICP) is the most common cholestatic liver disease during pregnancy. The reported incidence varies from 0.4 to 15% of full-term pregnancies.
Ropponen, Anne
core  

Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Integrated framework for tirzepatide in HFpEF management. Through metabolic, haemodynamic, structural and anti‐inflammatory pathways, tirzepatide modifies the disease trajectory of HFpEF, leading to improvements in symptoms, functional capacity and reduction in HF events.
Hamza A. Abdul‐Hafez   +9 more
wiley   +1 more source

Hodgkin Lymphoma With Liver Involvement (Diagnostic, Therapeutic Difficulties, and Literature Review): A Retrospective Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims In classical Hodgkin lymphoma liver involvement occurs in 5%–8%, ranging from mild dysfunction to acute liver failure. Recognition and treatment of advanced cases are challenging due to rapid progression and limited use of therapies. Methods We analyzed the data of 250 Hodgkin lymphoma patients; 9 had liver involvement, one
Fanni Borics   +6 more
wiley   +1 more source

The Effect of a Frailty Management Program on the Rehabilitation of Elderly Patients after Surgical Treatment [PDF]

open access: yes, 2015
The article performs the results of rehabilitation programs realized among senile patients after videolaparoscopic cholecystectomy, based on specific for geriatrics senile patients’ status assessment methods with determination of frailty and geriatric ...
Gorelik, S. G.   +3 more
core  

Weight‐Reduction and Safety Profile of Once‐Weekly Non‐Comparable Biotherapeutic Subcutaneous Semaglutide Among People With Obesity: A Real‐World Retrospective Study

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Semaglutide, a once‐weekly injectable glucagon‐like peptide, showed double‐digit weight reduction with an acceptable safety profile in clinical trials and real‐world studies. The efficacy and safety of non‐comparable biotherapeutic (NCB) semaglutide are not adequately reported. Our study aimed to assess the weight reduction
Md Rakibul Hasan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy